image credit: Freepik

Britain bets on biotech as billions set to boost life sciences sector

July 8, 2021


British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funneling £200 million to “specialist funds” designed to “unlock the potential of innovative U.K. life sciences companies so that they can grow their operations and create high-skilled jobs in the U.K.,” according to the government.

“The program will leverage further private sector investment and support the development of a world-leading U.K, life sciences venture capital,” the statement said.

Read More on FierceBiotech